Answers are grounded in this paper and cite their sources.
Bibliometric analysis reveals global trends and challenges in cervical cancer research over 24 years, indicating urgent areas for action.
Cervical cancer is the fourth most common malignant disease in women worldwide. Although the promotion and use of human papillomavirus (HPV) vaccinations have to some extent reduced the incidence of cervical cancer, problems persist, particularly in low- and middle-income nations. This bibliometric study, which shows the worldwide landscape of cervical cancer research from 2000 to 2024 through scientometric analysis of Web of Science Core Collection publications, provides significant insights into key research topics, new trends, and the networks of collaboration within this field. Early study concentrated on HPV's role in cervical cancer, whereas more recent studies highlight advances in HPV vaccinations, molecular biology, targeted therapies, and artificial intelligence applications in cervical cancer screening. However, global health disparities, vaccine accessibility, and regional disease burden remain significant challenges. This study provides a comprehensive summary for academics, clinicians, and policymakers to inform future research efforts to reduce the global incidence of cervical cancer.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: